Showing results (1251-1260 of 2,285) with videos related to

Sort By:
Pageof 229
HIV Medicine|December 12, 2001
Low body weight and type of protease inhibitor predict discontinuation and treatment-limiting adverse drug reactions among HIV-infected patients starting a protease inhibitor regimen: consistent results from a randomized trial and an observational cohortO Kirk, J Gerstoft, C Pedersen, et al.
HIV Medicine|December 12, 2001
L-Carnitine in the treatment of HIV-associated lipodystrophy syndromeS Mauss, G Schmutz
HIV Medicine|December 12, 2001
Principles and practice of HIV-protease inhibitor pharmacoenhancementG J Moyle, D Back
HIV Medicine|December 12, 2001
Candidate vaccines for immunotherapy in HIVF M Gotch, N Imami, G Hardy
HIV Medicine|May 16, 2002
The relationship between ritonavir plasma trough concentration and virological and immunological response in HIV-infected childrenG Gatti, E Pontali, S Boni, et al.
HIV Medicine|May 16, 2002
The changing demographics of new HIV diagnoses at a London centre from 1994 to 2000S M Barry, S J Lloyd-Owen, S J Madge, et al.
HIV Medicine|November 19, 2016
Higher rates of neuropsychiatric adverse events leading to dolutegravir discontinuation in women and older patientsC Hoffmann, T Welz, M Sabranski, et al.
HIV Medicine|September 29, 2016
Effect of alcohol consumption on all-cause and liver-related mortality among HIV-infected individualsC E Canan, B Lau, M E McCaul, et al.
HIV Medicine|December 22, 2016
A feasibility study for a clinical decision support system prompting HIV testingD R Chadwick, C Hall, C Rae, et al.
HIV Medicine|April 17, 2014
A comparison of computational models with and without genotyping for prediction of response to second-line HIV therapyA D Revell, M A Boyd, D Wang, et al.
Pageof 229